StemWave

Name

StemWave

Website

https://gostemwave.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Devices for Pain Management

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• Focused wave therapy
• Pain management devices
• Musculoskeletal treatment equipment
• Non-invasive medical devices
• Cellular response technology

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales: StemWave sells non-invasive focused wave medical devices to healthcare clinics and medical professionals. The company provides the device along with clinical training, business training, and marketing blueprints as part of the package. Pricing is based on device acquisition with treatment revenue generation for customers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

StemWave sells a non-invasive focused wave medical device branded StemWave® that uses proprietary Cellular Response Technology (CRT+) to support natural recovery for musculoskeletal conditions. The company distributes the device to medical professionals and healthcare clinics along with tailored clinical training, business training, and marketing blueprints, enabling clinics to treat neck/back, upper extremity, lower extremity, and soft tissue conditions in 10 minutes or less per session.

Product overview

StemWave offers a single core product platform — the StemWave® non-invasive focused wave device — which uses proprietary Cellular Response Technology (CRT+) to support natural recovery. The company provides the device along with tailored clinical training, business training, and marketing blueprints as part of a comprehensive clinic solution. Treatment versatility spans Neck & Back, Upper Extremities, Lower Extremities, and Soft Tissue applications. The average cost per treatment is stated at $150 over an 8-12 visit care plan.

Differentiator

Problem solved

Functional benefit

Products and services

• StemWave® Focused Wave Medical Device StemWave® is a non-invasive focused wave medical device that uses Cellular Response Technology (CRT+) to support natural recovery. It is designed for clinical use by doctors, physicians, and healthcare clinics to treat musculoskeletal conditions including neck and back pain, upper extremities (shoulder, elbow, wrist), lower extremities (knee, hip, ankle, foot), and soft tissue (muscles, tendons, ligaments). Treatments can be completed in 10 minutes or less per session, with an average treatment cost of $150 over an 8-12 visit care plan.

Quantifiable outcome

• Doctors adding $7k-$12k+ per month in additional collections
• +3 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Highly Successful Doctors (Training Partners)coreStrategic or Co-development PartnerStemWave has partnered with highly successful doctors to develop their clinical training program and proven treatment protocols. These partnerships are essential to creating credible, evidence-based protocols that drive the 99.1% success rate claimed by the company.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Storz Medical: Storz Medical is a leading manufacturer of focused and radial shockwave therapy systems used in orthopedics, rehabilitation, and pain management — directly competing with StemWave's CRT+ focused wave device across musculoskeletal indications.
• BTL Industries: BTL produces a broad portfolio of non-invasive medical and aesthetic devices including shockwave therapy systems sold to clinics and medical professionals, closely overlapping with StemWave's MSK and rehabilitation use cases and clinic-led GTM.
• Zimmer MedizinSysteme: Zimmer MedizinSysteme manufactures enPuls / enShock wave devices for musculoskeletal and pain indications, sold into physiotherapy and orthopedic clinics worldwide — a head-to-head competitor to StemWave in the focused/radial shockwave category.
• SoftWave Tissue Regeneration Technologies: SoftWave TRT markets unfocused/soft acoustic wave devices for orthopedic, pain, and urology indications to clinics and providers — a near-identical product positioning, customer base, and clinic-led sales model to StemWave.
• EMS Physio: EMS Physio manufactures shockwave therapy devices (Swiss DolorClast family) for musculoskeletal pain and rehabilitation, sold into physiotherapy and sports medicine clinics — directly comparable hardware, indications, and customer profile.
• Gymna (Gymna Uniphy): Gymna manufactures physiotherapy and rehabilitation equipment, including shockwave therapy devices used by the same PT and orthopedic clinic buyers that adopt StemWave for musculoskeletal indications.

Broad incumbents

• Chattanooga (DJO Global): Chattanooga / DJO is a broad incumbent in rehabilitation and orthopedic equipment, including Intelect shockwave and electrotherapy modalities, serving the same PT, chiropractic, and orthopedic clinic buyers that StemWave targets.

Emerging players

• SANUWAVE Health: SANUWAVE develops focused acoustic shockwave and ultrasound-based devices for wound healing and musculoskeletal applications, sharing the underlying physical mechanism and clinical user base with StemWave.
• InSightec: InSightec develops focused-ultrasound therapy systems for clinical use, sharing the 'non-invasive focused energy' category architecture with StemWave's focused wave platform, though serving different specialties today.

Regional players

• Richmar (Compass Health Brands): Richmar/Compass Health supplies a range of physical therapy and rehabilitation modalities — including ultrasound and electrotherapy — to US clinics, competing in adjacent equipment categories within the same MSK rehabilitation buyer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/StemWaveModusF

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about StemWave